CYP2C19 c.1A>G

CYP2C19 c.1A>G

The CYP2C19 c.1A>G Novallele Genotyping Assay identifies a single nucleotide change within the CYP2C19 gene associated with a common allele, CYP2C19*4. The CYP2C19*4 allele results in poor metabolism of a variety of drugs including mephenytoin, omeprazole, esomeprazole, and lansoprazole. The impact on drug metabolism is characterized by deficient synthesis of cholesterol, steroids and other lipids.

£177.00

Get in touch

Get in touch with the team

  • :

Product Description

The CYP2C19 c.1A>G Novallele Genotyping Assay is used to amplify and identify specific genetic polymorphisms or mutations. This assay provides scientists with a simple way to quickly genotype this locus from isolated human genomic DNA. The assay contains functionally-verified oligonucleotide primers necessary for PCR and subsequent allele identification by DNA melting. For Research Use Only. Not for use in diagnostic procedures.